VADUZ – October 27, 2026 -- Implantica AG has begun training its first U.S. surgeon on the RefluxStop anti-reflux implant, with the first U.S. procedures already scheduled at the University of Southern California (USC) after FDA approval in August 2026.

USC professor observes live RefluxStop procedures in Mainz

Dr. John C. Lipham, Professor of Surgery at USC, observed RefluxStop procedures performed by Dr. Moustafa Elshafei at Marienhaus Klinikum Mainz, Germany, on Monday, October 26. The observation is part of the training requirements for U.S. surgeons.

Washington D.C. – September 29, 2026 -- Implantica AG launched its FDA-approved RefluxStop device in the U.S. market at the American Foregut Society (AFS) 2026 Annual Meeting, drawing an over-capacity crowd of more than 120 surgeons and gastroenterologists that forced organizers to turn away additional attendees.